Organisation paid for research Program year 2025 Source: CMS Open Payments

Accellacare Piedmont

Neither a doctor nor a teaching hospital

Research payments

$117,185

6 payments

Through program year 2025, Accellacare Piedmont is reported as receiving $117,185 in research payments, across 6 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $936 2
2022 Research $14,850 2
2021 Research $101,399 2

Breakdown

Who paid Research payments · program years 2021–2025
  1. OraSure Technologies Inc. $116,249 4 payments
  2. Pfizer Inc. $936 2 payments
Studies the money was for Research payments · program years 2021–2025
  1. InteliSwab COVID-19 Rapid Test Clinical Evaluation Study in Asymptomatic Individuals $116,249 4 payments
  2. A Phase 3 Randomized Doubleblind Placebocontrolled Clinical Study Evaluating the Safety Tolerability Immunogenicity and Efficacy of A Variantadapted Bnt162b2 Vaccine in Healthy Participants 50 Through 64 Years of Age $936 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record